NYSEARCA:DSS - American Stock Exchange - US26253C2017 - Common Stock - Currency: USD
DSS INC
NYSEARCA:DSS (2/4/2025, 8:04:00 PM)
After market: 0.9689 +0.04 (+4.18%)0.93
+0.07 (+8.14%)
The current stock price of DSS is 0.93 USD. In the past month the price increased by 3.33%. In the past year, price decreased by -47.16%.
NEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) a multinational company operating businesses within diversified market sectors...
NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a dedicated supporter and investor in Impact BioMedical Inc. (NYSE American:...
NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- AmericaFirst Funds, a subsidiary of DSS, Inc. (NYSE American: DSS), today announced that effective August 9,...
NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) has announced the appointment of Jason Grady as its Interim CEO, effective...
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
BRC | BRADY CORPORATION - CL A | 17.24 | 3.57B | ||
CMPR | CIMPRESS PLC | 10.03 | 1.52B | ||
DLX | DELUXE CORP | 7.01 | 1.01B | ||
EBF | ENNIS INC | 13.03 | 538.72M | ||
QUAD | QUAD GRAPHICS INC | 10.03 | 371.09M | ||
SFHG | SAMFINE CREATION HOLDINGS GR | N/A | 20.30M |
DSS, Inc. engages in the development and distribution of paper products designed to protect valuable information from unauthorized scanning, copying, and digital imaging. The company is headquartered in West Henrietta, New York and currently employs 95 full-time employees. The company operates its business through six divisions: Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, Alternative Trading, and Direct Marketing. The Product Packaging division operates through Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through its operating company, American Pacific Bancorp, Inc., which represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena. Digital Transformation serves as a Preferred Technology Partner and Application Development Solution for mid-cap brands across various industries.
DSS INC
275 Wiregrass Pkwy
West Henrietta NEW YORK 14623 US
CEO: Frank D. Heuszel
Employees: 95
Company Website: https://www.dssworld.com/
Investor Relations: https://irdirect.net/dss
Phone: 15852321500
The current stock price of DSS is 0.93 USD.
The exchange symbol of DSS INC is DSS and it is listed on the American Stock Exchange exchange.
DSS stock is listed on the American Stock Exchange exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for DSS, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of DSS.
DSS does not pay a dividend.
DSS does not have a PE ratio as the earnings reported over the last twelve months were negative (-6.31).
The outstanding short interest for DSS is 0.49% of its float.
ChartMill assigns a technical rating of 1 / 10 to DSS. When comparing the yearly performance of all stocks, DSS is a bad performer in the overall market: 91.6% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to DSS. DSS may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months DSS reported a non-GAAP Earnings per Share(EPS) of -6.31. The EPS increased by 42.89% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -31.08% | ||
ROE | -85.08% | ||
Debt/Equity | 0.14 |
ChartMill assigns a Buy % Consensus number of 80% to DSS. The Buy consensus is the average rating of analysts ratings from 5 analysts.
For the next year, analysts expect an EPS growth of 100.38% and a revenue growth -0.25% for DSS